Medical Health Cluster

Vaccines

Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 Vaccination

In their new study, published in Circulation, the authors explained that myocarditis is more common after COVID-19 infection than after COVID-19 vaccination. However, the risks in younger people and after sequential vaccine doses were less certain. For the self-controlled case series study, the researchers used the National Immunisation Database of COVID-19 vaccination […]

Read More

El lastre mental que deja la covid: un estudio señala que el riesgo de problemas psiquiátricos sigue al alza dos años después del diagnóstico

El poso que deja la covid en el organismo sigue latente muchos meses después. Como un lastre que acompaña a las personas que han pasado la enfermedad, el riesgo de desarrollar algunas dolencias psiquiátricas y neurológicas, como los brotes psicóticos, la demencia, la niebla mental o la epilepsia, sigue al […]

Read More

Fighting current and future coronaviruses with a single vaccine

Vaccines against SARS-CoV-2, the virus that causes COVID-19, have greatly reduced the risk of severe disease and death. However, SARS-CoV-2 continues to mutate in unpredictable ways that can reduce the effectiveness of the current vaccines. The risk of a new coronavirus spilling over from animals to people also remains a […]

Read More

BCG Vaccine Protects Type 1 Diabetics Against COVID-19

Researchers at Massachusetts General Hospital (MGH), published a new paper in Cell Reports Medicine demonstrating the protective potential of multiple doses of the Bacillus Calmette-Guerin (BCG) vaccine against COVID-19 and other infectious diseases. In a double-blind, placebo-controlled study of patients with type 1 diabetes conducted at the start of the pandemic (before […]

Read More

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022

Summary What is already known about this topic? A Pfizer-BioNTech COVID-19 vaccine booster dose is recommended for children aged 5–11 years; approximately 657,302 third doses were administered to children in this age group during May–July 2022. What is added by this report? Among children aged 5–11 years, local and systemic […]

Read More

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

BackgroundUnderstanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally.MethodsThe GBD 2019 comparative risk assessment […]

Read More

Vaping’s Cardiopulmonary Associations in Adolescents Examined

Adolescents may experience short-term respiratory effects from vaping, such as coughing and wheezing, but studies are needed to determine long-term effects on their hearts and lungs, according to a recent scientific statement from the American Heart Association (AHA). The statement includes recommendations to curb adolescent vaping, which is the most popular way […]

Read More